IL231070A0 - Estrogen receptor ligands and methods of their use - Google Patents

Estrogen receptor ligands and methods of their use

Info

Publication number
IL231070A0
IL231070A0 IL231070A IL23107014A IL231070A0 IL 231070 A0 IL231070 A0 IL 231070A0 IL 231070 A IL231070 A IL 231070A IL 23107014 A IL23107014 A IL 23107014A IL 231070 A0 IL231070 A0 IL 231070A0
Authority
IL
Israel
Prior art keywords
methods
estrogen receptor
estrogen
receptor
Prior art date
Application number
IL231070A
Other languages
English (en)
Hebrew (he)
Original Assignee
Gtx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/215,679 external-priority patent/US9427418B2/en
Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en
Application filed by Gtx Inc filed Critical Gtx Inc
Publication of IL231070A0 publication Critical patent/IL231070A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL231070A 2011-08-23 2014-02-20 Estrogen receptor ligands and methods of their use IL231070A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/215,679 US9427418B2 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof
PCT/US2012/052141 WO2013043304A1 (en) 2009-02-23 2012-08-23 Estrogen receptor ligands and methods of use thereof

Publications (1)

Publication Number Publication Date
IL231070A0 true IL231070A0 (en) 2014-03-31

Family

ID=48444651

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231070A IL231070A0 (en) 2011-08-23 2014-02-20 Estrogen receptor ligands and methods of their use

Country Status (10)

Country Link
EP (1) EP2747562A4 (https=)
JP (1) JP2014524479A (https=)
KR (1) KR20140064906A (https=)
CN (1) CN103957706A (https=)
AU (1) AU2012312902B2 (https=)
CA (1) CA2845890A1 (https=)
IL (1) IL231070A0 (https=)
IN (1) IN2014DN01959A (https=)
MX (1) MX2014002105A (https=)
RU (1) RU2014111060A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020535171A (ja) * 2017-09-27 2020-12-03 ターグイミューン セラピューティクス アーゲー 去勢抵抗性前立腺癌
TWI840496B (zh) * 2019-01-30 2024-05-01 美商艾瑞岡醫藥公司 用於治療轉移性去勢敏感性前列腺癌之抗雄性激素
MX2021009119A (es) * 2019-02-01 2022-01-18 Fond Per Listituto Oncologico Di Ricerca Ior Metodos de tratamiento contra el cancer de prostata resistente a la castracion.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
EA201500845A1 (ru) * 2005-11-28 2016-04-29 Джи Ти Икс, ИНК. Агенты, связывающиеся с ядерными рецепторами
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
WO2010096801A1 (en) * 2009-02-23 2010-08-26 Gtx, Inc. Estrogen receptor ligands and methods of use thereof

Also Published As

Publication number Publication date
AU2012312902B2 (en) 2016-03-17
JP2014524479A (ja) 2014-09-22
KR20140064906A (ko) 2014-05-28
MX2014002105A (es) 2014-09-25
AU2012312902A1 (en) 2013-05-23
RU2014111060A (ru) 2015-09-27
CN103957706A (zh) 2014-07-30
EP2747562A1 (en) 2014-07-02
EP2747562A4 (en) 2015-05-06
CA2845890A1 (en) 2013-03-28
IN2014DN01959A (https=) 2015-05-15

Similar Documents

Publication Publication Date Title
IL227440A0 (en) Spherical support device and methods of use
IL232793A0 (en) Fluorine-converted estrogen receptor modulators and their uses
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
ZA201403760B (en) Anti-cd98 antibodies and methods of use thereof
SMT201900433T1 (it) Derivati di c4-monometil triterpenoidi e metodi del loro uso
IL232055B (en) Anti-1htra antibodies and methods of use
ZA201308022B (en) Anti-cd40 antibodies and methods of use
ZA201306451B (en) Anti-il-6 receptor antibodies and methods of use
ZA201307115B (en) Androgen receptor antagonists and uses thereof
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
EP2707036A4 (en) INTEGRIN RECEPTOR ANTAGONISTS AND METHOD FOR THEIR USE
SG11201502757QA (en) Anti-c16orf54 antibodies and methods of use thereof
EP2776437A4 (en) OPIOID RECEPTOR MODULATORS AND METHODS OF USE
ZA201300174B (en) Anti-neuropilin antibodies and methods of use
EP2709999A4 (en) QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE
IL214805A0 (en) Estrogen receptor ligands and methods of use thereof
EP2538780A4 (en) STROGEN RECEPTOR LIGANDS AND METHODS OF USE
EP2785742A4 (en) ANTI-KDR ANTIBODIES AND METHOD OF USE THEREOF
IL231070A0 (en) Estrogen receptor ligands and methods of their use
HK1173619A (en) Estrogen receptor ligands and methods of use thereof
GB201216724D0 (en) Note pad and method of use thereof